Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
2minutemedicine.com
18h
Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor therapy for synovial sarcoma
Afami-cel (Tecelra) is the first genetically engineered T-cell receptor therapy for synovial sarcoma Afami-cel demonstrated ...
2minutemedicine.com
20h
Semaglutide reduces heart failure events in patients with preserved ejection fraction
Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene now hurricane
Would-be assassin charged
Gets 2-yrs for role in fraud
Penn suspends law professor
Campaign office damaged
Study: Myopia on the rise
Woman dies in 'suicide pod’
To cut Atlanta service, jobs
First transparency report
CA new gun control laws
Union gets more voting time
Exec apologizes for outage
School book bans surge
Israel intercepts first missile
Chemical leak in OH county
NYC schools boss retiring
$375M military aid to UKR
Pac-12 sues Mountain West
New home sales fall
New COVID, flu shots
Briefed on Iranian threats
US to waive visas for Qatar
Calls strike against 'LoL’
Fat Bear Week coming up
Texas AG appeal denied
China conducts ICBM test
InfoWars to be auctioned off
Feedback